Skip to main content

Table 1 The patients’ characteristics in the study groups

From: Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial

Variables

Experimental group

(n = 58)

Control group

(n = 58)

P value

Age (years)

38.1 ± 4.64

38.9 ± 4.0

0.28

BMI (kg/m2)

27.50 ± 0.46

26.80 ± 0.48

0.55

Duration of infertility (years)

5.02 ± 5.01

6.50 ± 5.41

0.13

Total antral follicles count

4.75 ± 1.87

4.70± 2.28

0.89

Basal serum FSH (mIU/m)

8.2 ± 3.0

8.5 ± 2.7

0.51

Basal serum LH (mIU/ml)

4.41 ± 4.91

5.53± 7.03

0.24

Serum AMH (ng/ml)

1.0 ± 0.9

0.8 ± 0.6

0.70

Basal Estradiol (pg/ml)

44.89 ± 4.42

52.37 ± 4.83

0.14

Basal progesterone (ng/ml)

0.48 ± 0.03

0.44 ± 0.03

0.85

No. of previous IVF

0.43± 0.85

0.36 ± 0.64

0.90

  1. BMI body mass index, No. number, FSH follicle-stimulating hormone, LH luteinizing hormone, AMH anti-Müllerian hormone, IVF in vitro fertilization